Cameco Stock Down to Below $90 -- Is Now the Time to Buy?

Cameco closed at $85.69 on Oct. 1, down from a 52-week high of $135.24, while the article argues that long-term uranium demand and contracting support its outlook despite valuation risk. Q2 adjusted EBITDA was about $279 million and adjusted net earnings about $55 million, both below a year earlier; Cameco maintained 2026 attributable uranium production guidance of 19.5–21.5 million pounds. It had $784 million in cash, $713 million in debt and a further $713 million available on its revolving credit facility.

Analysis

The key mispricing risk is treating uncovered uranium requirements through 2045 as near-term demand. Those estimates support a long-cycle contracting thesis, but do not establish when utilities will sign, what prices they will accept, or how much demand can be met through inventories and secondary supply. The near-term earnings bridge is therefore contracting cadence and realized contract economics—not reactor demand headlines alone.

Cameco’s integrated exposure is a partial hedge, not a clean one: uranium operations face mine, transport, and processing bottlenecks, while Westinghouse adds a separate project-execution and servicing cycle. The Cigar Lake ownership increase raises Cameco’s share of potential output but also concentrates exposure to a mine whose processing depends on third-party infrastructure. Any disruption can delay deliveries even if the long-term market remains tight.

Over days to weeks, price action may continue to track uranium sentiment and valuation compression. Over 1–3 months, watch new term-contract awards, realized uranium prices, and updates on Saskatchewan logistics and McClean Lake processing. Over 6–18 months, sustained utility contracting could convert the long-dated deficit narrative into firmer cash-flow visibility. Conversely, delayed contracting, secondary supply, or production slippage would expose the premium multiple. The contrarian point: the pullback may improve entry, but it does not by itself make the stock inexpensive; the article provides no valuation or contract-pricing data to establish that conclusion.

Key Decisions for Investors

• Avoid buying solely on the 2045 uncovered-requirements estimate. Verify term-market contracting volumes and Cameco’s realized contract prices before upgrading the earnings thesis.
• For investors seeking exposure, consider a staged Cameco entry rather than a full position now; add only if production guidance holds and contracting evidence improves. Falsify the setup on a guidance cut, persistent delivery disruption, or weakening term contracting.
• Track Cigar Lake and McClean Lake operating updates as a company-specific supply catalyst: increased ownership amplifies both upside from reliable output and downside from mine, mill, or transport interruptions.
• No clean relative-value or options trade is supported by the supplied data. Reassess after comparing Cameco’s valuation with peers and confirming the uranium spot-versus-term price trend and contract economics.